Skip to main content
EMVISION MEDICAL DEVICES LTD logo

EMVISION MEDICAL DEVICES LTD — Investor Relations & Filings

Ticker · EMV ISIN · AU0000028375 ASX Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2022-11-30 Share Issue/Capital Cha…
Country AU Australia
Listing ASX EMV

About EMVISION MEDICAL DEVICES LTD

https://emvision.com.au/

EMVision Medical Devices Ltd is a medical technology company focused on the development and commercialization of portable medical imaging devices. The company specializes in electromagnetic microwave imaging technology designed for the rapid diagnosis and monitoring of stroke and traumatic brain injury. Its primary product is a portable brain scanner intended for use at the point of care, including intensive care units, emergency departments, and ambulances. By utilizing non-ionizing radiation, the technology provides a safe, cost-effective, and mobile alternative to traditional neuroimaging modalities like CT and MRI. The device aims to facilitate earlier clinical intervention by enabling bedside assessment, potentially improving patient outcomes through faster detection of ischemic and hemorrhagic strokes.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - EMV 8 pages 34.9KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Notification of Issue, Conversion or Payment up of Unquoted Equity Securities' and details the issuance of unquoted securities (options) under an employee incentive scheme by Emvision Medical Devices Ltd. It includes specifics such as security descriptions, issue dates, number of securities issued, and mentions key management personnel involved. The document is a formal notification to the ASX regarding new securities issued, which fits the category of announcements related to share issues or capital changes. There is no indication that this is a full financial report, earnings release, or management discussion. The content aligns with announcements about new share issues or capital changes rather than other categories like regulatory filings or director dealings. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length (9380 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2022-11-30 English
Change of Director's Interest Notice X 6 17 pages 402.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in directors' relevant interests in securities, including the number of shares and options held before and after the change, the nature of the change, and the value/consideration. The document is a formal notification of personal share transactions by company directors. It does not contain financial performance data, earnings, or management discussion, but rather focuses on insider share transactions by directors. Therefore, it fits the definition of Director's Dealing (DIRS).
2022-11-30 English
EMVision Commences Clinical Trial 2 pages 162.3KB
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 30/11/22 from EMVision Medical Devices Ltd providing an update on the commencement of a clinical trial. It includes details about user training completion, trial stages, and a CEO comment. There are no financial statements, regulatory certifications, or detailed financial data. The document is an operational update rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Audit Report. It is also not a management or board change announcement, nor a capital or financing update. The content is a general company update on clinical trial progress, which is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2022-11-29 English
AGM Chairman Address and Presentation 8 pages 988.2KB
AGM Information Classification · 100% confidence The document is titled 'AGM CHAIRMAN’S ADDRESS & PRESENTATION' and includes a Chairman's address and CEO presentation to be made at the company's 2022 Annual General Meeting (AGM). It discusses company progress, funding, clinical trials, and strategic updates, typical content for AGM materials. The document is about 15,000 characters, indicating it is a full presentation rather than a brief announcement. There is no indication that this is a full Annual Report, Earnings Release, or other financial report. The content is clearly related to the AGM meeting materials, including speeches and presentations. Therefore, the document fits the category of AGM Information (AGM-R).
2022-11-15 English
Results of Annual General Meeting 3 pages 143.0KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULTS OF ANNUAL GENERAL MEETING' and details the voting outcomes of resolutions passed at the company's AGM held on 16-Nov-22. It includes proxy vote counts and percentages for each resolution, consistent with official announcements of shareholder voting results. The document is relatively short (3418 characters) and does not contain financial statements or detailed reports, but rather the official voting results. According to the classification rules, such documents reporting official shareholder vote outcomes at a general meeting are classified as Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-11-15 English
Portable Brain Scanner Delivered to First Clinical Site 2 pages 162.6KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing the delivery of a portable brain scanner to the first clinical site for a multi-centre trial. It includes statements from the CEO about the significance of this milestone and forward-looking statements about the company's plans and expectations. There are no financial statements, regulatory form references, or detailed financial data. The document is an operational update rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is also not a report publication announcement since it does not mention any report being attached or published. The content is best classified as a general regulatory announcement about company progress and clinical trial status, which fits the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other categories.
2022-11-13 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.